MediWound files to sell 1.45M ordinary shares for holders
MDWD Stock | USD 17.52 0.06 0.34% |
About 53% of Mediwound's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Mediwound stock suggests that some investors are interested at this time. The current market sentiment, together with Mediwound's historical and current headlines, can help investors time the market. In addition, many technical investors use Mediwound stock news signals to limit their universe of possible portfolio assets.
Mediwound | Build AI portfolio with Mediwound Stock |
MediWound filed a prospectus related to a new financial offering, signaling potential growth and investment opportunities in the company.
Read at seekingalpha.com
![]() |
Mediwound Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Mediwound can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Mediwound Fundamental Analysis
We analyze Mediwound's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mediwound using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mediwound based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Mediwound is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Mediwound Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mediwound stock to make a market-neutral strategy. Peer analysis of Mediwound could also be used in its relative valuation, which is a method of valuing Mediwound by comparing valuation metrics with similar companies.
Peers
Mediwound Related Equities
SNDX | Syndax Pharmaceuticals | 10.21 | ||||
KRON | Kronos Bio | 1.39 | ||||
SANA | Sana Biotechnology | 0.55 | ||||
SWTX | SpringWorks Therapeutics | 0.13 | ||||
INBX | Inhibrx | 0.71 | ||||
REPL | Replimune | 0.77 | ||||
DYAI | Dyadic International | 0.93 | ||||
NKTX | Nkarta | 1.03 | ||||
KROS | Keros Therapeutics | 2.64 | ||||
RNA | Avidity Biosciences | 2.86 | ||||
GLUE | Monte Rosa | 3.08 | ||||
MRUS | Merus BV | 4.37 | ||||
VCYT | Veracyte | 4.81 | ||||
OCUL | Ocular Therapeutix | 5.23 | ||||
MLYS | Mineralys Therapeutics, | 6.15 | ||||
CRNX | Crinetics Pharmaceuticals | 6.18 | ||||
LYEL | Lyell Immunopharma | 6.98 | ||||
FHTX | Foghorn Therapeutics | 7.28 | ||||
GBIO | Generation Bio | 7.69 | ||||
STRO | Sutro Biopharma | 9.37 |
Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |